127 related articles for article (PubMed ID: 12660017)
21. DNA binding properties of the indolocarbazole antitumor drug NB-506.
Carrasco C; Vezin H; Wilson WD; Ren J; Chaires JB; Bailly C
Anticancer Drug Des; 2001; 16(2-3):99-107. PubMed ID: 11962518
[TBL] [Abstract][Full Text] [Related]
22. Syntheses, biochemical and biological evaluation of staurosporine analogues from the microbial metabolite rebeccamycin.
Anizon F; Moreau P; Sancelme M; Voldoire A; Prudhomme M; Ollier M; Sevère D; Riou JF; Bailly C; Fabbro D; Meyer T; Aubertin AM
Bioorg Med Chem; 1998 Sep; 6(9):1597-604. PubMed ID: 9801830
[TBL] [Abstract][Full Text] [Related]
23. Formaldehyde-induced alkylation of a 2'-aminoglucose rebeccamycin derivative to both A.T and G.C base pairs in DNA.
Bailly C; Goossens JF; Laine W; Anizon F; Prudhomme M; Ren J; Chaires JB
J Med Chem; 2000 Nov; 43(24):4711-20. PubMed ID: 11101362
[TBL] [Abstract][Full Text] [Related]
24. Syntheses and biological evaluation of indolocarbazoles, analogues of rebeccamycin, modified at the imide heterocycle.
Moreau P; Anizon F; Sancelme M; Prudhomme M; Bailly C; Carrasco C; Ollier M; Sevère D; Riou JF; Fabbro D; Meyer T; Aubertin AM
J Med Chem; 1998 May; 41(10):1631-40. PubMed ID: 9572888
[TBL] [Abstract][Full Text] [Related]
25. Plasma stability of two glycosyl indolocarbazole antitumor agents.
Goossens JF; Kluza J; Vezin H; Kouach M; Briand G; Baldeyrou B; Wattez N; Bailly C
Biochem Pharmacol; 2003 Jan; 65(1):25-34. PubMed ID: 12473375
[TBL] [Abstract][Full Text] [Related]
26. Cellular uptake and interaction with purified membranes of rebeccamycin derivatives.
Goossens JF; Hénichart JP; Anizon F; Prudhomme M; Dugave C; Riou J; Bailly C
Eur J Pharmacol; 2000 Feb; 389(2-3):141-6. PubMed ID: 10688977
[TBL] [Abstract][Full Text] [Related]
27. The biosynthetic gene cluster for the antitumor rebeccamycin: characterization and generation of indolocarbazole derivatives.
Sánchez C; Butovich IA; Braña AF; Rohr J; Méndez C; Salas JA
Chem Biol; 2002 Apr; 9(4):519-31. PubMed ID: 11983340
[TBL] [Abstract][Full Text] [Related]
28. Indolocarbazole antitumour compounds by combinatorial biosynthesis.
Salas JA; Méndez C
Curr Opin Chem Biol; 2009 Apr; 13(2):152-60. PubMed ID: 19251468
[TBL] [Abstract][Full Text] [Related]
29. Targeting topoisomerase I cleavage to specific sequences of DNA by triple helix-forming oligonucleotide conjugates. A comparison between a rebeccamycin derivative and camptothecin.
Arimondo PB; Bailly C; Boutorine A; Sun JS; Garestier T; Hélène C
C R Acad Sci III; 1999 Sep; 322(9):785-90. PubMed ID: 10547719
[TBL] [Abstract][Full Text] [Related]
30. Combinatorial biosynthesis of antitumor indolocarbazole compounds.
Sánchez C; Zhu L; Braña AF; Salas AP; Rohr J; Méndez C; Salas JA
Proc Natl Acad Sci U S A; 2005 Jan; 102(2):461-6. PubMed ID: 15625109
[TBL] [Abstract][Full Text] [Related]
31. Topoisomerase I-mediated DNA cleavage as a guide to the development of antitumor agents derived from the marine alkaloid lamellarin D: triester derivatives incorporating amino acid residues.
Tardy C; Facompré M; Laine W; Baldeyrou B; García-Gravalos D; Francesch A; Mateo C; Pastor A; Jiménez JA; Manzanares I; Cuevas C; Bailly C
Bioorg Med Chem; 2004 Apr; 12(7):1697-712. PubMed ID: 15028262
[TBL] [Abstract][Full Text] [Related]
32. NB-506, an indolocarbazole topoisomerase I inhibitor, binds preferentially to triplex DNA.
Ren J; Bailly C; Chaires JB
FEBS Lett; 2000 Mar; 470(3):355-9. PubMed ID: 10745096
[TBL] [Abstract][Full Text] [Related]
33. Syntheses and biological activities of rebeccamycin analogues. Introduction of a halogenoacetyl substituent.
Moreau P; Anizon F; Sancelme M; Prudhomme M; Bailly C; Sevère D; Riou JF; Fabbro D; Meyer T; Aubertin AM
J Med Chem; 1999 Feb; 42(4):584-92. PubMed ID: 10052965
[TBL] [Abstract][Full Text] [Related]
34. The camptothecin-resistant topoisomerase I mutant F361S is cross-resistant to antitumor rebeccamycin derivatives. A model for topoisomerase I inhibition by indolocarbazoles.
Bailly C; Carrasco C; Hamy F; Vezin H; Prudhomme M; Saleem A; Rubin E
Biochemistry; 1999 Jul; 38(27):8605-11. PubMed ID: 10393535
[TBL] [Abstract][Full Text] [Related]
35. Intercalation into DNA is not required for inhibition of topoisomerase I by indolocarbazole antitumor agents.
Bailly C; Dassonneville L; Colson P; Houssier C; Fukasawa K; Nishimura S; Yoshinari T
Cancer Res; 1999 Jun; 59(12):2853-60. PubMed ID: 10383146
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, biological evaluation, and molecular modeling studies of rebeccamycin analogues modified in the carbohydrate moiety.
Animati F; Berettoni M; Bigioni M; Binaschi M; Felicetti P; Gontrani L; Incani O; Madami A; Monteagudo E; Olivieri L; Resta S; Rossi C; Cipollone A
ChemMedChem; 2008 Feb; 3(2):266-79. PubMed ID: 18157856
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological activities of 7-aza rebeccamycin analogues bearing the sugar moiety on the nitrogen of the pyridine ring.
Messaoudi S; Anizon F; Peixoto P; David-Cordonnier MH; Golsteyn RM; Léonce S; Pfeiffer B; Prudhomme M
Bioorg Med Chem; 2006 Nov; 14(22):7551-62. PubMed ID: 16889964
[TBL] [Abstract][Full Text] [Related]
38. Recognition and cleavage of DNA by rebeccamycin- or benzopyridoquinoxaline conjugated of triple helix-forming oligonucleotides.
Arimondo PB; Moreau P; Boutorine A; Bailly C; Prudhomme M; Sun JS; Garestier T; Hélène C
Bioorg Med Chem; 2000 Apr; 8(4):777-84. PubMed ID: 10819166
[TBL] [Abstract][Full Text] [Related]
39. Structure-activity relationships in a series of substituted indolocarbazoles: topoisomerase I and protein kinase C inhibition and antitumoral and antimicrobial properties.
Pereira ER; Belin L; Sancelme M; Prudhomme M; Ollier M; Rapp M; Sevère D; Riou JF; Fabbro D; Meyer T
J Med Chem; 1996 Oct; 39(22):4471-7. PubMed ID: 8893841
[TBL] [Abstract][Full Text] [Related]
40. Methylenedioxy- and ethylenedioxy-fused indolocarbazoles: potent human topoisomerase I inhibitors and antitumor agents.
Zembower DE; Xie Y; Koohang A; Kuffel MJ; Ames MM; Zhou Y; Mishra R; Mar AA; Flavin MT; Xu ZQ
Anticancer Agents Med Chem; 2012 Nov; 12(9):1117-31. PubMed ID: 22339065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
